TickerFactsScreenerDevelopers

Kiniksa Pharmaceuticals International, plc (KNSA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$65.40M2018: -$108.16M2019: -$169.96M2020: -$157.36M2021: -$156.64M2022: $9.77M2023: -$25.20M2024: -$45.62M2025: $77.22M$77.22M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$77.22M+269.3%
2024-$45.62M-81.0%
2023-$25.20M-357.8%
2022$9.77M+106.2%
2021-$156.64M+0.5%
2020-$157.36M+7.4%
2019-$169.96M-57.1%
2018-$108.16M-65.4%
2017-$65.40M—